JP2008509950A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008509950A5 JP2008509950A5 JP2007526351A JP2007526351A JP2008509950A5 JP 2008509950 A5 JP2008509950 A5 JP 2008509950A5 JP 2007526351 A JP2007526351 A JP 2007526351A JP 2007526351 A JP2007526351 A JP 2007526351A JP 2008509950 A5 JP2008509950 A5 JP 2008509950A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- dioxo
- imidazolidin
- thiazol
- butyramide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 42
- 150000001875 compounds Chemical class 0.000 claims description 25
- 125000000623 heterocyclic group Chemical group 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 8
- 125000003386 piperidinyl group Chemical group 0.000 claims description 8
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000005415 substituted alkoxy group Chemical group 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
- -1 2,3-dihydro-benzo [1,4] dioxin-6-yl Chemical group 0.000 claims 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 3
- RJZPPHJGWOCMBW-MUEKUWCCSA-N (2s,3s)-2-[(4r)-4-[4-(2-ethoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound C1=CC(OCCOCC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(=O)CC)C(=O)N1 RJZPPHJGWOCMBW-MUEKUWCCSA-N 0.000 claims 2
- UMXZLBLGVVFRBS-AJHZIAPWSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-[2-(2-methoxyethylamino)-2-oxoethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(OCC(=O)NCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)C(=O)N1 UMXZLBLGVVFRBS-AJHZIAPWSA-N 0.000 claims 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- GKDVIQCISXZIDJ-XYHYBEPMSA-N (2s,3r)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylmethoxy-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)OCC=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCCOC)=CC=2)=O)=N1 GKDVIQCISXZIDJ-XYHYBEPMSA-N 0.000 claims 1
- UWIMTNBKRFQIBP-PIVNMMCNSA-N (2s,3s)-2-[(4r)-2,5-dioxo-4-[4-(2-oxo-2-pyrrolidin-1-ylethoxy)phenyl]imidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCC(=O)N3CCCC3)=CC=2)=O)=N1 UWIMTNBKRFQIBP-PIVNMMCNSA-N 0.000 claims 1
- FAOHSPUFQXWJSD-RVHYNSKXSA-N (2s,3s)-2-[(4r)-2,5-dioxo-4-phenylimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC=CC=2)=O)=N1 FAOHSPUFQXWJSD-RVHYNSKXSA-N 0.000 claims 1
- MYZYOAYFZLVXEM-BJQRDSPESA-N (2s,3s)-2-[(4r)-4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=C3OCCOC3=CC=2)=O)=N1 MYZYOAYFZLVXEM-BJQRDSPESA-N 0.000 claims 1
- ZVJVPWWPRFINEV-IPVSCWGHSA-N (2s,3s)-2-[(4r)-4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,5-dioxoimidazolidin-1-yl]-n-[4-(1-hydroxypropyl)-1,3-thiazol-2-yl]-3-phenylbutanamide Chemical compound CCC(O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=C3OCCOC3=CC=2)=O)=N1 ZVJVPWWPRFINEV-IPVSCWGHSA-N 0.000 claims 1
- HAZKEOXELTWJOJ-FNVCAUGXSA-N (2s,3s)-2-[(4r)-4-(4-ethoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound C1=CC(OCC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(=O)CC)C(=O)N1 HAZKEOXELTWJOJ-FNVCAUGXSA-N 0.000 claims 1
- RTIYENHYKKZGAW-DLPLYFIVSA-N (2s,3s)-2-[(4r)-4-(4-hydroxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(O)=CC=2)=O)=N1 RTIYENHYKKZGAW-DLPLYFIVSA-N 0.000 claims 1
- LJFHMSZDUOLYML-FNVCAUGXSA-N (2s,3s)-2-[(4r)-4-(4-methoxy-3-methylphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=C(C)C(OC)=CC=2)=O)=N1 LJFHMSZDUOLYML-FNVCAUGXSA-N 0.000 claims 1
- IMAFKJGJDAVAAF-ARBPTSGCSA-N (2s,3s)-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OC)=CC=2)=O)=N1 IMAFKJGJDAVAAF-ARBPTSGCSA-N 0.000 claims 1
- BJJARBIKZKHELT-USCONSEESA-N (2s,3s)-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-n-[4-(2-methylpropanoyl)-1,3-thiazol-2-yl]-3-phenylbutanamide Chemical compound C1=CC(OC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(=O)C(C)C)C(=O)N1 BJJARBIKZKHELT-USCONSEESA-N 0.000 claims 1
- BGIUACCETCLDJH-VWMXVWASSA-N (2s,3s)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCCOC)=CC=2)=O)=N1 BGIUACCETCLDJH-VWMXVWASSA-N 0.000 claims 1
- FEBIHWITJUHRRD-PIVNMMCNSA-N (2s,3s)-2-[(4r)-4-[4-(2-morpholin-4-yl-2-oxoethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCC(=O)N3CCOCC3)=CC=2)=O)=N1 FEBIHWITJUHRRD-PIVNMMCNSA-N 0.000 claims 1
- RKSDGUHTDQMJOZ-VWMXVWASSA-N (2s,3s)-2-[(4r)-4-[4-(dimethoxyphosphorylmethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCP(=O)(OC)OC)=CC=2)=O)=N1 RKSDGUHTDQMJOZ-VWMXVWASSA-N 0.000 claims 1
- AMPKJLPGYRHJKY-YZYNAAERSA-N (2s,3s)-2-[(4r)-4-[4-[2-(2-methoxyethoxy)ethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCCOCCOC)=CC=2)=O)=N1 AMPKJLPGYRHJKY-YZYNAAERSA-N 0.000 claims 1
- IAUOMVZXRVQRFV-IMDCKVJKSA-N (2s,3s)-2-[(4r)-4-[4-[2-(2-methoxyethylamino)-2-oxoethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCC(=O)NCCOC)=CC=2)=O)=N1 IAUOMVZXRVQRFV-IMDCKVJKSA-N 0.000 claims 1
- VDVGIQBCLJZKGN-IMDCKVJKSA-N (2s,3s)-2-[(4r)-4-[4-[2-(azetidin-1-yl)-2-oxoethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCC(=O)N3CCC3)=CC=2)=O)=N1 VDVGIQBCLJZKGN-IMDCKVJKSA-N 0.000 claims 1
- CAMWINXAXRFDEZ-AJHZIAPWSA-N (2s,3s)-2-[(4r)-4-[4-[2-(dimethylamino)-2-oxoethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCC(=O)N(C)C)=CC=2)=O)=N1 CAMWINXAXRFDEZ-AJHZIAPWSA-N 0.000 claims 1
- MZUVQFITLDJWGN-GHEQTVGYSA-N (2s,3s)-2-[(4r)-4-[4-[2-(methylamino)-2-oxoethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCC(=O)NC)=CC=2)=O)=N1 MZUVQFITLDJWGN-GHEQTVGYSA-N 0.000 claims 1
- RKKBPPTYPGTSEA-GMWOSMDTSA-N (2s,3s)-2-[(4s)-4-[4-(2-hydroxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@@H](NC2=O)C=2C=CC(OCCO)=CC=2)=O)=N1 RKKBPPTYPGTSEA-GMWOSMDTSA-N 0.000 claims 1
- BGIUACCETCLDJH-DPSWKAHMSA-N (2s,3s)-2-[(4s)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@@H](NC2=O)C=2C=CC(OCCOC)=CC=2)=O)=N1 BGIUACCETCLDJH-DPSWKAHMSA-N 0.000 claims 1
- WQDCOBMQXXDLQY-GHSRMECKSA-N (2s,3s)-2-[2,5-dioxo-4-[4-(2-piperidin-1-ylethoxy)phenyl]imidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C(C(NC2=O)C=2C=CC(OCCN3CCCCC3)=CC=2)=O)=N1 WQDCOBMQXXDLQY-GHSRMECKSA-N 0.000 claims 1
- OEJOYGTVAKZGIC-VNYPPZAHSA-N (2s,3s)-2-[4-(4-morpholin-4-ylphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C(C(NC2=O)C=2C=CC(=CC=2)N2CCOCC2)=O)=N1 OEJOYGTVAKZGIC-VNYPPZAHSA-N 0.000 claims 1
- XLUICOHNWYWEFQ-JUJMCKSGSA-N (2s,3s)-2-[4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-methyl-n-(4-propanoyl-1,3-thiazol-2-yl)pentanamide Chemical compound O=C1N([C@@H]([C@@H](C)CC)C(=O)NC=2SC=C(N=2)C(=O)CC)C(=O)NC1C1=CC=C(OCCOC)C=C1 XLUICOHNWYWEFQ-JUJMCKSGSA-N 0.000 claims 1
- VKWWTAMMAHEBEQ-AXFKQKATSA-N (2s,3s)-2-[4-[4-(2-morpholin-4-ylethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C(C(NC2=O)C=2C=CC(OCCN3CCOCC3)=CC=2)=O)=N1 VKWWTAMMAHEBEQ-AXFKQKATSA-N 0.000 claims 1
- NYPKIANNZDNFPU-XLXODUMSSA-N (2s,3s)-2-[4-[4-(4-hydroxypiperidin-1-yl)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C(C(NC2=O)C=2C=CC(=CC=2)N2CCC(O)CC2)=O)=N1 NYPKIANNZDNFPU-XLXODUMSSA-N 0.000 claims 1
- PZDHZYLTWQSYHM-VNYPPZAHSA-N (2s,3s)-2-[4-[4-[2-methoxyethyl(methyl)amino]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenyl-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C(C(NC2=O)C=2C=CC(=CC=2)N(C)CCOC)=O)=N1 PZDHZYLTWQSYHM-VNYPPZAHSA-N 0.000 claims 1
- VAAZPRCSKQZJQC-GHEQTVGYSA-N (2s,3s)-3-(3-fluorophenyl)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-n-(4-propanoyl-1,3-thiazol-2-yl)butanamide Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=C(F)C=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCCOC)=CC=2)=O)=N1 VAAZPRCSKQZJQC-GHEQTVGYSA-N 0.000 claims 1
- ZLLIAKYXUIPBIT-ARBPTSGCSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-(4-ethoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(OCC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)C(=O)N1 ZLLIAKYXUIPBIT-ARBPTSGCSA-N 0.000 claims 1
- CWBSOUADJQDOSQ-SVIJTADQSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-(4-hydroxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)=CC=C(O)C=C1 CWBSOUADJQDOSQ-SVIJTADQSA-N 0.000 claims 1
- VKJCLKODXRCZBO-DLPLYFIVSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(OC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)C(=O)N1 VKJCLKODXRCZBO-DLPLYFIVSA-N 0.000 claims 1
- KVKDDSXNZUDXOA-NNWRFLSQSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylpentanamide Chemical compound C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@@H](CC)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)=CC=C(OC)C=C1 KVKDDSXNZUDXOA-NNWRFLSQSA-N 0.000 claims 1
- AYTSWSRJBHEGRA-CUJSYCCXSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-(2-amino-2-oxoethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)=CC=C(OCC(N)=O)C=C1 AYTSWSRJBHEGRA-CUJSYCCXSA-N 0.000 claims 1
- NTHXESUFIMQJEQ-IMDCKVJKSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-(2-morpholin-4-yl-2-oxoethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC([C@H]2NC(=O)N(C2=O)[C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)=CC=C1OCC(=O)N1CCOCC1 NTHXESUFIMQJEQ-IMDCKVJKSA-N 0.000 claims 1
- IVEOUGNWZPSZFV-MUEKUWCCSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-[2-(2-methoxyethoxy)ethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(OCCOCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)C(=O)N1 IVEOUGNWZPSZFV-MUEKUWCCSA-N 0.000 claims 1
- PWLYBDLYHRZXGA-GHEQTVGYSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-[2-(dimethylamino)-2-oxoethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)=CC=C(OCC(=O)N(C)C)C=C1 PWLYBDLYHRZXGA-GHEQTVGYSA-N 0.000 claims 1
- JSYKNZZNYKBHEK-BZRZBQBMSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-[2-(dimethylamino)ethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)=CC=C(OCCN(C)C)C=C1 JSYKNZZNYKBHEK-BZRZBQBMSA-N 0.000 claims 1
- COENBVRHWRZWRY-BJQRDSPESA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-[2-(methylamino)-2-oxoethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(OCC(=O)NC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)C(=O)N1 COENBVRHWRZWRY-BJQRDSPESA-N 0.000 claims 1
- TYDPBHFDHQJMBG-LZCUNHEZSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[4-(4-diethoxyphosphorylphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(P(=O)(OCC)OCC)=CC=C1C1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)C(=O)N1 TYDPBHFDHQJMBG-LZCUNHEZSA-N 0.000 claims 1
- BRTXZYZIRRXRIJ-QEKIYOMCSA-N (2s,3s)-n-(4-acetyl-1,3-thiazol-2-yl)-2-[4-[4-(dimethylamino)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound O=C1N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)=O)C(=O)NC1C1=CC=C(N(C)C)C=C1 BRTXZYZIRRXRIJ-QEKIYOMCSA-N 0.000 claims 1
- BNBBUNOMDOUOGX-IMRHEYAYSA-N (2s,3s)-n-(4-ethylsulfanyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound CCSC1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCCOC)=CC=2)=O)=N1 BNBBUNOMDOUOGX-IMRHEYAYSA-N 0.000 claims 1
- UOTMFRIADITBII-IPAURDGOSA-N (2s,3s)-n-(4-ethylsulfinyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound CCS(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCCOC)=CC=2)=O)=N1 UOTMFRIADITBII-IPAURDGOSA-N 0.000 claims 1
- BGAGIUFVXNPXBW-IMRHEYAYSA-N (2s,3s)-n-(4-ethylsulfonyl-1,3-thiazol-2-yl)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound CCS(=O)(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCCOC)=CC=2)=O)=N1 BGAGIUFVXNPXBW-IMRHEYAYSA-N 0.000 claims 1
- CSXJWCCKICAWRW-FNVCAUGXSA-N (2s,3s)-n-[4-(2-hydroxyacetyl)-1,3-thiazol-2-yl]-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(OCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(=O)CO)C(=O)N1 CSXJWCCKICAWRW-FNVCAUGXSA-N 0.000 claims 1
- FYAINSINUCXREV-VWMXVWASSA-N (2s,3s)-n-[4-(cyclopropanecarbonyl)-1,3-thiazol-2-yl]-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(OCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(=O)C2CC2)C(=O)N1 FYAINSINUCXREV-VWMXVWASSA-N 0.000 claims 1
- WZYXLAVDBCMKRS-GHEQTVGYSA-N (2s,3s)-n-[4-(cyclopropanecarbonyl)-1,3-thiazol-2-yl]-2-[(4r)-4-[4-[2-(methylamino)-2-oxoethoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(OCC(=O)NC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(=O)C2CC2)C(=O)N1 WZYXLAVDBCMKRS-GHEQTVGYSA-N 0.000 claims 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims 1
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical group CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 claims 1
- XFQXSMXNNQHINY-OPILKIMUSA-N 2-[4-[2,5-dioxo-1-[(2s,3s)-1-oxo-3-phenyl-1-[(4-propanoyl-1,3-thiazol-2-yl)amino]butan-2-yl]imidazolidin-4-yl]phenoxy]acetic acid Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C(C(NC2=O)C=2C=CC(OCC(O)=O)=CC=2)=O)=N1 XFQXSMXNNQHINY-OPILKIMUSA-N 0.000 claims 1
- YHFQRWKRHLCXJR-RVHYNSKXSA-N 2-[[(2s,3s)-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-n,n-dimethyl-1,3-thiazole-4-carboxamide Chemical compound C1=CC(OC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(=O)N(C)C)C(=O)N1 YHFQRWKRHLCXJR-RVHYNSKXSA-N 0.000 claims 1
- 125000000872 2-diethylaminoethoxy group Chemical group [H]C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- RKKBPPTYPGTSEA-FNVCAUGXSA-N RO4927350 Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCCO)=CC=2)=O)=N1 RKKBPPTYPGTSEA-FNVCAUGXSA-N 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- YDQDLFQOHXRYFT-GHEQTVGYSA-N methyl 2-[4-[(4r)-2,5-dioxo-1-[(2s,3s)-1-oxo-3-phenyl-1-[(4-propanoyl-1,3-thiazol-2-yl)amino]butan-2-yl]imidazolidin-4-yl]phenoxy]acetate Chemical compound CCC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCC(=O)OC)=CC=2)=O)=N1 YDQDLFQOHXRYFT-GHEQTVGYSA-N 0.000 claims 1
- PPMXETHXODZNIC-WOJBJXKFSA-N methyl 2-[[(2s)-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-methyl-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@@H](N2C([C@H](NC2=O)C=2C=CC(OC)=CC=2)=O)C(C)(C)C=2C=CC=CC=2)=N1 PPMXETHXODZNIC-WOJBJXKFSA-N 0.000 claims 1
- CUQZQHVLJVTAOI-IFZYUDKTSA-N methyl 2-[[(2s,3r)-2-[(4r)-4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=C3OCCOC3=CC=2)=O)=N1 CUQZQHVLJVTAOI-IFZYUDKTSA-N 0.000 claims 1
- RQRLHETVEAMLLF-LYRGGWFBSA-N methyl 2-[[(2s,3r)-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-methylpentanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@H](C)CC)C(=O)NC=2SC=C(N=2)C(=O)OC)=CC=C(OC)C=C1 RQRLHETVEAMLLF-LYRGGWFBSA-N 0.000 claims 1
- YUHMIVPGCKUVSN-ZMYBRWDISA-N methyl 2-[[(2s,3r)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-[(2-methylpropan-2-yl)oxy]butanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1=CC(OCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)OC(C)(C)C)C(=O)NC=2SC=C(N=2)C(=O)OC)C(=O)N1 YUHMIVPGCKUVSN-ZMYBRWDISA-N 0.000 claims 1
- UWQOCAVQZYAIFW-XWIAVFTESA-N methyl 2-[[(2s,3r)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-methylpentanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@H](C)CC)C(=O)NC=2SC=C(N=2)C(=O)OC)=CC=C(OCCOC)C=C1 UWQOCAVQZYAIFW-XWIAVFTESA-N 0.000 claims 1
- WGDWYZSBVAQWQN-ZQMYSKGWSA-N methyl 2-[[(2s,3r)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylmethoxybutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1=CC(OCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)OCC=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(=O)OC)C(=O)N1 WGDWYZSBVAQWQN-ZQMYSKGWSA-N 0.000 claims 1
- HVAHSGWGDBJCHI-FZQKWOKYSA-N methyl 2-[[(2s,3r)-3-hydroxy-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]butanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)O)N2C([C@H](NC2=O)C=2C=CC(OC)=CC=2)=O)=N1 HVAHSGWGDBJCHI-FZQKWOKYSA-N 0.000 claims 1
- JJUBLXHBGVUHGS-LYRGGWFBSA-N methyl 2-[[(2s,3r)-3-hydroxy-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]butanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1=CC(OCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)O)C(=O)NC=2SC=C(N=2)C(=O)OC)C(=O)N1 JJUBLXHBGVUHGS-LYRGGWFBSA-N 0.000 claims 1
- JDIUNKBCVACKEH-KMUNFCNLSA-N methyl 2-[[(2s,3r)-3-methoxy-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]butanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@@H](C)OC)C(=O)NC=2SC=C(N=2)C(=O)OC)=CC=C(OC)C=C1 JDIUNKBCVACKEH-KMUNFCNLSA-N 0.000 claims 1
- CMPBBNZVDPTSJX-JLZZUVOBSA-N methyl 2-[[(2s,3r)-3-methoxy-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]butanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1=CC(OCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)OC)C(=O)NC=2SC=C(N=2)C(=O)OC)C(=O)N1 CMPBBNZVDPTSJX-JLZZUVOBSA-N 0.000 claims 1
- PGXLBJUAUFKALR-USCONSEESA-N methyl 2-[[(2s,3s)-2-[(4r)-2,5-dioxo-4-(4-propan-2-yloxyphenyl)imidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OC(C)C)=CC=2)=O)=N1 PGXLBJUAUFKALR-USCONSEESA-N 0.000 claims 1
- CUQZQHVLJVTAOI-DLPLYFIVSA-N methyl 2-[[(2s,3s)-2-[(4r)-4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=C3OCCOC3=CC=2)=O)=N1 CUQZQHVLJVTAOI-DLPLYFIVSA-N 0.000 claims 1
- HWEQFBVEAVUCCM-DLPLYFIVSA-N methyl 2-[[(2s,3s)-2-[(4r)-4-(4-acetamidophenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(NC(C)=O)=CC=2)=O)=N1 HWEQFBVEAVUCCM-DLPLYFIVSA-N 0.000 claims 1
- GUVRHNNNBJYKSK-BKTGTZMESA-N methyl 2-[[(2s,3s)-2-[(4r)-4-(4-hydroxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(O)=CC=2)=O)=N1 GUVRHNNNBJYKSK-BKTGTZMESA-N 0.000 claims 1
- WLQJWIUIHWHAAT-RVHYNSKXSA-N methyl 2-[[(2s,3s)-2-[(4r)-4-(4-methoxy-3-methylphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=C(C)C(OC)=CC=2)=O)=N1 WLQJWIUIHWHAAT-RVHYNSKXSA-N 0.000 claims 1
- RQRLHETVEAMLLF-XZJROXQQSA-N methyl 2-[[(2s,3s)-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-methylpentanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@@H](C)CC)C(=O)NC=2SC=C(N=2)C(=O)OC)=CC=C(OC)C=C1 RQRLHETVEAMLLF-XZJROXQQSA-N 0.000 claims 1
- RNQOXMDLWNHJTE-KPOBHBOGSA-N methyl 2-[[(2s,3s)-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OC)=CC=2)=O)=N1 RNQOXMDLWNHJTE-KPOBHBOGSA-N 0.000 claims 1
- NINQMMPLKCFPKC-RVHYNSKXSA-N methyl 2-[[(2s,3s)-2-[(4r)-4-[4-(2-hydroxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCCO)=CC=2)=O)=N1 NINQMMPLKCFPKC-RVHYNSKXSA-N 0.000 claims 1
- UWQOCAVQZYAIFW-VHSSKADRSA-N methyl 2-[[(2s,3s)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-methylpentanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1([C@H]2NC(=O)N(C2=O)[C@@H]([C@@H](C)CC)C(=O)NC=2SC=C(N=2)C(=O)OC)=CC=C(OCCOC)C=C1 UWQOCAVQZYAIFW-VHSSKADRSA-N 0.000 claims 1
- GYOZDUDRHGPQBS-USCONSEESA-N methyl 2-[[(2s,3s)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1=CC(OCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(=O)OC)C(=O)N1 GYOZDUDRHGPQBS-USCONSEESA-N 0.000 claims 1
- FTSHKUAMSVGXLP-USCONSEESA-N methyl 2-[[(2s,3s)-2-[(4r)-4-[4-(dimethoxyphosphorylmethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C=CC=CC=2)N2C([C@H](NC2=O)C=2C=CC(OCP(=O)(OC)OC)=CC=2)=O)=N1 FTSHKUAMSVGXLP-USCONSEESA-N 0.000 claims 1
- AAEDIUPCKIHNOW-YZIZEKMBSA-N methyl 2-[[(2s,3s)-3-(2-methoxyphenyl)-2-[4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]butanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound COC(=O)C1=CSC(NC(=O)[C@H]([C@@H](C)C=2C(=CC=CC=2)OC)N2C(C(NC2=O)C=2C=CC(OC)=CC=2)=O)=N1 AAEDIUPCKIHNOW-YZIZEKMBSA-N 0.000 claims 1
- BBUCEHDVMJNHMU-ARBPTSGCSA-N methyl 2-[[(2s,3s)-3-(4-fluorophenyl)-2-[(4r)-4-[4-(2-methoxyethoxy)phenyl]-2,5-dioxoimidazolidin-1-yl]butanoyl]amino]-1,3-thiazole-4-carboxylate Chemical compound C1=CC(OCCOC)=CC=C1[C@@H]1C(=O)N([C@@H]([C@@H](C)C=2C=CC(F)=CC=2)C(=O)NC=2SC=C(N=2)C(=O)OC)C(=O)N1 BBUCEHDVMJNHMU-ARBPTSGCSA-N 0.000 claims 1
- CLCDQYYRHRVFEF-VZDHWGDASA-N n-[4-(2-hydroxypropan-2-yl)-1,3-thiazol-2-yl]-2-[(4r)-4-(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-3-phenylbutanamide Chemical compound C1=CC(OC)=CC=C1[C@@H]1C(=O)N(C(C(C)C=2C=CC=CC=2)C(=O)NC=2SC=C(N=2)C(C)(C)O)C(=O)N1 CLCDQYYRHRVFEF-VZDHWGDASA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical group CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60217504P | 2004-08-17 | 2004-08-17 | |
| US60/602,175 | 2004-08-17 | ||
| US68299705P | 2005-05-20 | 2005-05-20 | |
| US60/682,997 | 2005-05-20 | ||
| PCT/EP2005/008633 WO2006018188A2 (en) | 2004-08-17 | 2005-08-09 | Substituted hydantoins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008509950A JP2008509950A (ja) | 2008-04-03 |
| JP2008509950A5 true JP2008509950A5 (OSRAM) | 2012-01-05 |
| JP4927733B2 JP4927733B2 (ja) | 2012-05-09 |
Family
ID=35589619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526351A Expired - Fee Related JP4927733B2 (ja) | 2004-08-17 | 2005-08-09 | 置換ヒダントイン |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7427635B2 (OSRAM) |
| EP (1) | EP1781649B1 (OSRAM) |
| JP (1) | JP4927733B2 (OSRAM) |
| KR (2) | KR20090006885A (OSRAM) |
| AR (1) | AR050297A1 (OSRAM) |
| AT (1) | ATE404556T1 (OSRAM) |
| AU (1) | AU2005274390B2 (OSRAM) |
| BR (1) | BRPI0514515A (OSRAM) |
| CA (1) | CA2576599A1 (OSRAM) |
| DE (1) | DE602005008986D1 (OSRAM) |
| ES (1) | ES2313389T3 (OSRAM) |
| MX (1) | MX2007001846A (OSRAM) |
| PL (1) | PL1781649T3 (OSRAM) |
| RU (1) | RU2383542C2 (OSRAM) |
| TW (1) | TW200621764A (OSRAM) |
| WO (1) | WO2006018188A2 (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200621766A (en) * | 2004-09-17 | 2006-07-01 | Hoffmann La Roche | Substituted hydantoins |
| US7612212B2 (en) * | 2006-02-22 | 2009-11-03 | Hoffmann-La Roche Inc. | Substituted hydantoins |
| JP2010526848A (ja) * | 2007-05-11 | 2010-08-05 | エフ．ホフマン−ラ ロシュ アーゲー | 難溶性薬物用の医薬組成物 |
| ES2383927T3 (es) | 2007-08-16 | 2012-06-27 | F. Hoffmann-La Roche Ag | Hidantoínas sustituidas |
| CN101896469A (zh) * | 2007-12-20 | 2010-11-24 | 霍夫曼-拉罗奇有限公司 | 作为mek激酶抑制剂的取代的乙内酰脲类化合物 |
| US8822513B2 (en) | 2010-03-01 | 2014-09-02 | Gtx, Inc. | Compounds for treatment of cancer |
| US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
| US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| DK2959900T3 (en) * | 2008-06-16 | 2017-06-26 | Univ Tennessee Res Found | CONNECTION TO TREATMENT OF CANCER |
| EP2370568B1 (en) | 2008-12-10 | 2017-07-19 | Dana-Farber Cancer Institute, Inc. | Mek mutations conferring resistance to mek inhibitors |
| TW201113280A (en) * | 2009-07-03 | 2011-04-16 | Nensius Res As | Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the CNS |
| EP3028699B1 (en) | 2010-02-25 | 2018-03-21 | Dana-Farber Cancer Institute, Inc. | Braf mutations conferring resistance to braf inhibitors |
| EP2542081A4 (en) | 2010-03-01 | 2013-07-31 | Gtx Inc | COMPOSITIONS FOR CANCER TREATMENT |
| BR112012022801B8 (pt) | 2010-03-09 | 2019-10-29 | Dana Farber Cancer Inst Inc | método de identificar um indivíduo que tem câncer que é provável beneficiar-se do tratamento com uma terapia de combinação com um inibidor de raf e um segundo inibidor e uso de um inibidor de raf e um segundo inibidor para a fabricação de um medicamento para tratar câncer |
| EP2563786B1 (de) | 2010-04-28 | 2016-11-02 | Bayer Intellectual Property GmbH | Ketoheteroarylpiperidin und -piperazin Derivate als Fungizide |
| US20150141470A1 (en) | 2012-05-08 | 2015-05-21 | The Broad Institute, Inc. | Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy |
| SG11202100531RA (en) * | 2018-09-17 | 2021-02-25 | Yungjin Pharm Co Ltd | Novel thiazole derivatives and pharmaceutically acceptable salts thereof |
| KR102335637B1 (ko) * | 2020-03-13 | 2021-12-06 | 영진약품 주식회사 | 신규한 cdk7 억제 화합물 및 이의 약제학적으로 허용가능한 염 |
| US20230095520A1 (en) * | 2020-03-13 | 2023-03-30 | Yungjin Pharm. Co., Ltd. | Pharmaceutical composition for preventing or treating cancer comprising azole derivatives or pharmaceutically acceptable salt thereof |
| KR20210146144A (ko) | 2020-05-26 | 2021-12-03 | 엘지전자 주식회사 | 카트부 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| CA2290506C (en) | 1997-07-01 | 2005-12-27 | Warner-Lambert Company | 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| EP1280801B1 (en) * | 2000-05-03 | 2005-09-07 | F. Hoffmann-La Roche Ag | Hydantoin-containing glucokinase activators |
| NZ530524A (en) * | 2001-07-19 | 2006-12-22 | Pharmacia Italia S | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
-
2005
- 2005-08-09 DE DE602005008986T patent/DE602005008986D1/de not_active Expired - Lifetime
- 2005-08-09 PL PL05771890T patent/PL1781649T3/pl unknown
- 2005-08-09 RU RU2007109651/04A patent/RU2383542C2/ru not_active IP Right Cessation
- 2005-08-09 CA CA002576599A patent/CA2576599A1/en not_active Abandoned
- 2005-08-09 JP JP2007526351A patent/JP4927733B2/ja not_active Expired - Fee Related
- 2005-08-09 EP EP05771890A patent/EP1781649B1/en not_active Expired - Lifetime
- 2005-08-09 BR BRPI0514515-5A patent/BRPI0514515A/pt not_active IP Right Cessation
- 2005-08-09 WO PCT/EP2005/008633 patent/WO2006018188A2/en not_active Ceased
- 2005-08-09 KR KR1020087032084A patent/KR20090006885A/ko not_active Ceased
- 2005-08-09 AU AU2005274390A patent/AU2005274390B2/en not_active Ceased
- 2005-08-09 ES ES05771890T patent/ES2313389T3/es not_active Expired - Lifetime
- 2005-08-09 MX MX2007001846A patent/MX2007001846A/es active IP Right Grant
- 2005-08-09 KR KR1020077004075A patent/KR100889721B1/ko not_active Expired - Fee Related
- 2005-08-09 AT AT05771890T patent/ATE404556T1/de active
- 2005-08-11 US US11/202,299 patent/US7427635B2/en not_active Expired - Fee Related
- 2005-08-15 TW TW094127672A patent/TW200621764A/zh unknown
- 2005-08-16 AR ARP050103440A patent/AR050297A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008509950A5 (OSRAM) | ||
| JP5675773B2 (ja) | Ｃｃｒ２の４−アゼチジニル−１−フェニル−シクロヘキサンアンタゴニスト | |
| ES2240558T3 (es) | Derivados de tiazol y oxazol como activadores de receptores activados por el proliferador de peroxisoma humano. | |
| JP5244863B2 (ja) | ジオキサン−２−アルキルカルバメート誘導体の製造法およびその中間体 | |
| RU2383542C2 (ru) | Замещенные гидантоины | |
| RU2007116317A (ru) | Гексафторизопропанол-замещенные производные простых эфиров | |
| JP2009508963A5 (OSRAM) | ||
| JP2009538333A5 (OSRAM) | ||
| JP2005511766A5 (OSRAM) | ||
| JP2007519692A5 (OSRAM) | ||
| JP4796046B2 (ja) | ピペリジニルアルキルカーバメートの誘導体、これらの製造方法及びｆａａｈ酵素インヒビターとしての使用 | |
| JP2006506380A5 (OSRAM) | ||
| AU2010236336B2 (en) | 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of CCR2 | |
| JP2010504323A5 (OSRAM) | ||
| JP2004507501A5 (OSRAM) | ||
| KR101972619B1 (ko) | 페닐 유도체 | |
| RU2007103304A (ru) | Новые производные гексафторизопропанола | |
| CA2598516A1 (en) | Benzisoxazole derivatives | |
| JP2008540595A5 (OSRAM) | ||
| JPWO2021007663A5 (OSRAM) | ||
| KR20140117301A (ko) | 페닐 유도체를 함유하는 의약 | |
| JP2006509022A5 (OSRAM) | ||
| US8440819B2 (en) | Therapeutic substituted beta-lactams | |
| RU2006102866A (ru) | Тиазолзамещенные индолилпроизводные и их применение в качестве модуляторов ppar | |
| JP2007532576A5 (OSRAM) |